Fibrinogen: A cardiovascular risk factor;Fibrinogene: Facteur de risque cardiovasculaire

Presse Medicale

Volumn 29, Issue 34, 2000, Pages 1862-1866

  Colas, J L ^a   Montalescot, G ^a   Tribouilloy, C ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ANGINA PECTORIS; AORTA ATHEROSCLEROSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; LEG ARTERY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SUDDEN DEATH; THORACIC AORTA; TRANSIENT ISCHEMIC ATTACK; ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA DISEASE; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LEG; LIFESTYLE; MALE; PHYSIOLOGY; PREGNANCY; PROSPECTIVE STUDY; RISK; SMOKING; VASCULARIZATION;

ADULT; AGED; AORTIC DISEASES; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; FIBRINOGEN; HUMANS; LEG; LIFE STYLE; MALE; PREGNANCY; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SMOKING;

EID: 0034645057     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. The possible role of hemorheology in atherothrombogenesis
2. Haemostatic factors in human aortic intima
3. Fate of fibrinogen in human arterial intima
4. Identification and distribution of fibrinogen, fibrin, and fibrinogen degradation products in atherosclerosis: Use of monoclonal antibodies
5. ECAT angina pectoris study: Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography
6. Influence of platelet size on out-come after myocardial infarction
7. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: The Scottish Heart Health Study
8. Fibrinogen is an independent marker for thoracic aortic atherosclerosis
9. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
10. Fibrinogen, factor VII clotting activity and coronary artery disease severity
11. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis
12. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
13. Fibrinogen and risk of cardiovascular disease The Framingham Study
14. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease
15. Fibrinogen as a risk factor for stroke and myocardial infarction
16. Fibrinogen as cardiovascular risk factor: A meta-analysis and review of the literature
17. Fibrinogen after coronary angioplasty as a risk factor for restenosis
18. Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation
19. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors
20. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study
21. Inter-relationships of plasma fibrinogen, LDL-cholesterol, cigarette smoking and the prevalence of cardiovascular disease
22. The influence of fibrinogen concentration on the development of vein graft stenoses
23. A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants
24. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
25. Effect of atorvastatin on plasma fibrinogen
26. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
27. Lowering fibrinogen levels: Clinical update. BIP Study group. Bezafibrate Infarction Prevention